Literature DB >> 18346572

Balloon control of the suprahepatic inferior vena cava: a novel technique for renal cell carcinoma tumor thrombus.

David A Rigberg1, Juan Carlos Jimenez, Peter F Lawrence.   

Abstract

Renal cell carcinoma has a tendency to extend via the renal vein into the inferior vena cava (IVC), and we describe a novel approach to this situation. A 64-year-old male presented with metastatic right renal cell carcinoma and tumor thrombus extending into the retrohepatic IVC. Preoperative imaging revealed a large hemangioma adjacent to the IVC, potentially complicating hepatic mobilization. Instead, we used a compliant balloon to occlude the suprahepatic IVC, securing the wire in the right hepatic vein. With the infrarenal IVC and left renal vein occluded, the thrombus was extracted via a right renal venotomy/partial cavotomy with minimal bleeding. Balloon occlusion of the suprahepatic IVC offers a safe alternative to surgical control of this vessel in difficult situations. In addition, it allows for nephrectomy through a conventional, small retroperitoneal incision rather than the extended exposure needed for the IVC. Hepatic vein positioning of the wire prevents thrombus manipulation during balloon placement.

Entities:  

Mesh:

Year:  2008        PMID: 18346572     DOI: 10.1016/j.avsg.2007.12.003

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  New method for treatment of inferior vena cava tumor thrombus – case study.

Authors:  Zoltán Nagy; Endre Gyurkovics; Péter Pajor; Mária Tarjányi; Attila Szijártó; Sandor G Vari
Journal:  Croat Med J       Date:  2015-04       Impact factor: 1.351

2.  Modified technique of cavoatrial tumor thrombectomy without cardiopulmonary by-pass and hypothermic circulatory arrest: a preliminary report.

Authors:  Robert Sobczyński; Tomasz Golabek; Mikolaj Przydacz; Tomasz Wiatr; Jakub Bukowczan; Jerzy Sadowski; Piotr Chłosta
Journal:  Cent European J Urol       Date:  2015-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.